{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:55:15Z","timestamp":1785876915319,"version":"3.56.0"},"reference-count":45,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health, USA","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health, USA","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health, USA","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"LSU Research Enhancement Program bridge","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"LSU Research Enhancement Program bridge","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"LSU Research Enhancement Program bridge","doi-asserted-by":"publisher","award":["CA218764"],"award-info":[{"award-number":["CA218764"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Human neuroblastoma (NB) is the most common childhood extracranial tumor arising from the sympathetic nervous system. It is also a clinically heterogeneous disease that ranges from spontaneous regression to high-risk stage 4 disease. The cause of this disease remains elusive. However, the amplification of NMYC oncogene occurred in roughly 30% of NB patients, which strongly correlated with the advanced stage of disease subtype and the worse prognosis status. We discovered that N-Myc oncoprotein binds and activates INSM1, a zinc-finger transcription factor of neuroendocrine tumors. We also found that INSM1 modulates N-Myc stability mediated through PI3K\/AKT\/GSK3\u03b2 signaling pathway. Therefore, INSM1 emerges as a critical co-player with N-Myc in facilitating NB tumor cell growth and sustaining the advanced stage of malignancy. Using an INSM1-promoter driven luciferase screening-platform, we have recently identified fifteen small molecules that negatively regulate INSM1 expression. Interestingly, the identified small molecules can be divided into four large groups of compounds such as cell signaling inhibitor, DNA\/RNA inhibitor, HDAC inhibitor, and cardiac glycoside. These findings support the presence of a unique mechanism associated with INSM1 and N-Myc interplay, which is critical in regulating NB tumor cell growth. We discuss the feasibility of identifying novel or repurposing small molecules targeting INSM1 as a potential treatment option for high-risk NB.<\/jats:p>","DOI":"10.3390\/biology12081134","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T11:06:16Z","timestamp":1692097576000},"page":"1134","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Small Molecules Targeting INSM1 for the Treatment of High-Risk Neuroblastoma"],"prefix":"10.3390","volume":"12","author":[{"given":"Michael S.","family":"Lan","sequence":"first","affiliation":[{"name":"Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiachen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0028-1111294","article-title":"Development and present status of neuroendocrinology","volume":"90","author":"Harris","year":"1965","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_2","unstructured":"Heitz, P.U., Roth, J., Zuber, C., and Komminoth, P. (1991). Markers for Neural and Endocrine Cells in Pathology, VCH Publishers, Inc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15252","DOI":"10.1016\/S0021-9258(18)42173-4","article-title":"A novel human insulinoma-associated cDNA, IA-1, encodes a protein with zinc-finger DNA-binding motifs","volume":"267","author":"Goto","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"38991","DOI":"10.1074\/jbc.M306795200","article-title":"NeuroD1\/E47 regulates the E-box element of a novel zinc-finger transcription factor, IA-1, in developing nervous system","volume":"278","author":"Breslin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","article-title":"INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms","volume":"144","author":"Rosenbaum","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/PAS.0000000000000916","article-title":"INSM1 Demonstrates Superior Performance to the individual and combined use of Synaptophysin, Chromogranin, and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity","volume":"41","author":"Rooper","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00795-017-0167-6","article-title":"Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor","volume":"51","author":"Tanigawa","year":"2018","journal-title":"Med. Mol. Morphol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1242\/dev.011783","article-title":"Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage","volume":"135","author":"Wildner","year":"2008","journal-title":"Development"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7150\/thno.47525","article-title":"Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics","volume":"11","author":"Bao","year":"2021","journal-title":"Theranostics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncy.21972","article-title":"Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens","volume":"126","author":"Doxtader","year":"2018","journal-title":"Cancer Cytopathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1038\/s41467-022-35214-4","article-title":"TBX2 specifies and maintains inner hair and supporting cell fate in the Organ of Corti","volume":"13","author":"Kaiser","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1749-8104-6-6","article-title":"Insm1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic","volume":"6","author":"Rosenbaum","year":"2011","journal-title":"Neural Dev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ccell.2014.09.019","article-title":"ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma","volume":"26","author":"Bresler","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1038\/sj.onc.1208157","article-title":"The Phox2B homeobox gene is mutated in sporadic neuroblastomas","volume":"23","author":"Schramm","year":"2004","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1470-2045(03)01283-X","article-title":"Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma","volume":"4","author":"Mosse","year":"2003","journal-title":"Lancet Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-3016.2008.00983.x","article-title":"The epidemiology of neuroblastoma: A review","volume":"23","author":"Heck","year":"2009","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/374640a0","article-title":"Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development","volume":"374","author":"Zhou","year":"1995","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/374643a0","article-title":"Noradrenaline is essential for mouse fetal development","volume":"374","author":"Thompson","year":"1995","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1074\/jbc.RA118.006761","article-title":"5\u2032-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth","volume":"294","author":"Chen","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"110753","DOI":"10.1016\/j.cellsig.2023.110753","article-title":"Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma","volume":"109","author":"Chen","year":"2023","journal-title":"Cell. Signal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41598-019-54350-4","article-title":"Haspin-dependent and independent effects of the kinase inhibitor 5-Iodotubercidin on self-renewal and differentiation","volume":"10","author":"Karanika","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/onc.2008.316","article-title":"Nucleoside analogs: Molecular mechanisms signaling cell death","volume":"27","author":"Ewald","year":"2008","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhang, X., Jia, D., Liu, H., Zhu, N., Zhang, W., Feng, J., Yin, J., Hao, B., Cui, D., and Deng, Y. (2013). Identification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potential. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062527"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","article-title":"AKT as a Therapeutic Target for Cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"key":"ref_26","unstructured":"Carmen Avendono, J.C.M. (2015). Anticancer Drugs Acting via Radical Species: Radiotherapy and Photodynamic Therapy of Cancer, Elsevier. Chapter 4."},{"key":"ref_27","unstructured":"Wexler, P. (2014). Mithramycin, Academic Press."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dozic, S., Howden, E.J., Bell, J.R., Mellor, K.M., Delbridge, L.M.D., and Weeks, K.L. (2023). Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy. Cells, 12.","DOI":"10.3390\/cells12091312"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00282-997-0163-8","article-title":"Mitoxantrone in the treatment of acute myelogenous leukemia: A review","volume":"39","author":"Thomas","year":"1997","journal-title":"Hematol. Cell Ther."},{"key":"ref_31","first-page":"10","article-title":"Overview of mitoxantrone-a potential candidate for treatment of breast cancer","volume":"14","author":"Preethi","year":"2022","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1271\/bbb.58.1579","article-title":"Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells","volume":"58","author":"Ueda","year":"1994","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/1078-0432.CCR-07-4262","article-title":"Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma","volume":"14","author":"Ellis","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bouyahya, A., El Omari, N., Bakha, M., Aanniz, T., El Menyiy, N., El Hachlafi, N., El Baaboua, A., El-Shazly, M., Alshahrani, M.M., and Al Awadh, A.A. (2022). Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review. Pharmaceuticals, 15.","DOI":"10.3390\/ph15101235"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2478\/v10042-008-0019-2","article-title":"Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells","volume":"46","author":"Pajak","year":"2008","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sztiller-Sikorska, M., and Czyz, M. (2020). Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies. Pharmaceuticals, 13.","DOI":"10.3390\/ph13080194"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/1078-0432.CCR-13-1283","article-title":"Omacetaxine: A protein translation inhibitor for treatment of chronic myelogenous leukemia","volume":"20","author":"Gandhi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2010-01-262808","article-title":"Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2011.01.009","article-title":"Common cardiovascular medications in cancer therapeutics","volume":"130","author":"Vaklavas","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1002\/ijc.29217","article-title":"Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours","volume":"136","author":"Braekeveldt","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_41","first-page":"77","article-title":"Biologically relevant orthotopic neuroblastoma xenograft models: Primary adrenal tumor growth and spontaneous distant metastasis","volume":"16","author":"Khanna","year":"2002","journal-title":"In Vivo"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/nm.2454","article-title":"Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes","volume":"17","author":"DeRose","year":"2011","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1093\/emboj\/16.11.2985","article-title":"Targeted expression of N-myc causes neuroblastoma in transgenic mice","volume":"16","author":"Weiss","year":"1997","journal-title":"EMBO J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-94-017-7215-0_9","article-title":"Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects","volume":"867","author":"Isgro","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/CCLM.1998.042","article-title":"Neuron-specific enolase: Reference values in cord blood","volume":"36","author":"Kintzel","year":"1998","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/8\/1134\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:33:49Z","timestamp":1760128429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/8\/1134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["biology12081134"],"URL":"https:\/\/doi.org\/10.3390\/biology12081134","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]}}}